Manikandan Subramanian
Overview
Explore the profile of Manikandan Subramanian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
2205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Subramanian M, Sarasamma J, Krishnan K
Environ Monit Assess
. 2024 Nov;
196(12):1199.
PMID: 39546091
The present study was aimed at investigating the source, quality, and quantity of organic matter and labile fraction of biochemical constituents in the surficial sediments of Arabian Sea Shoreline at...
2.
Bhattacharya P, Dhawan U, Hussain M, Singh P, Kiran Bhagat K, Singhal A, et al.
Cell Rep
. 2023 Jul;
42(7):112808.
PMID: 37436891
Macrophages release soluble mediators following efferocytic clearance of apoptotic cells to facilitate intercellular communication and promote the resolution of inflammation. However, whether inflammation resolution is modulated by extracellular vesicles (EVs)...
3.
Resolution pharmacology - A fresh approach to the clinical management of human inflammatory diseases
Perretti M, Subramanian M
Semin Immunol
. 2022 Dec;
65:101669.
PMID: 36565567
No abstract available.
4.
Dhawan U, Margraf A, Lech M, Subramanian M
J Cell Mol Med
. 2022 Sep;
26(20):5267-5276.
PMID: 36098213
Hypercholesterolemia exacerbates autoimmune response and accelerates the progression of several autoimmune disorders, but the mechanistic basis is not well understood. We recently demonstrated that hypercholesterolemia is associated with increased serum...
5.
Bhattacharya P, Kanagasooriyan R, Subramanian M
Curr Opin Pharmacol
. 2022 Aug;
66:102283.
PMID: 36037627
Atherosclerosis is a lipid-driven disease of the artery characterized by chronic non-resolving inflammation. Despite availability of excellent lipid-lowering therapies, atherosclerosis remains the leading cause of disability and death globally. The...
6.
Manickam V, Dhawan U, Singh D, Gupta M, Subramanian M
Front Pharmacol
. 2022 Jun;
13:888300.
PMID: 35721222
Atherosclerosis is a chronic lipid-driven inflammatory condition of the arteries and is a leading cause of stroke, myocardial infarction, and other peripheral arterial diseases. Plant products rich in polyphenols such...
7.
Dhawan U, Bhattacharya P, Narayanan S, Manickam V, Aggarwal A, Subramanian M
Arterioscler Thromb Vasc Biol
. 2021 Aug;
41(10):2598-2615.
PMID: 34348488
Objective: Hypercholesterolemia-induced NETosis and accumulation of neutrophil extracellular traps (NETs) in the atherosclerotic lesion exacerbates inflammation and is causally implicated in plaque progression. We investigated whether hypercholesterolemia additionally impairs the...
8.
Subramanian M, Marelli-Berg F
Cell Metab
. 2021 Aug;
33(8):1509-1511.
PMID: 34348095
The tumor microenvironment is immunosuppressive. Here we preview two recent studies from Ma et al. (2021) in Cell Metabolism and Xu et al. (2021) in Immunity that describe a key...
9.
Dhawan U, Singhal A, Subramanian M
Pharmacol Res
. 2021 Jun;
170:105699.
PMID: 34087352
Phagocytic clearance of dead cells and debris is critical for inflammation resolution and maintenance of tissue homeostasis. Consequently, defective clearance of dead cells and debris is associated with initiation and...
10.
Naushin S, Sardana V, Ujjainiya R, Bhatheja N, Kutum R, Bhaskar A, et al.
Elife
. 2021 Apr;
10.
PMID: 33876727
To understand the spread of SARS-CoV2, in August and September 2020, the Council of Scientific and Industrial Research (India) conducted a serosurvey across its constituent laboratories and centers across India....